Genetic factors linked to heart, kidney, and diabetes risks in NHPI people
Official title: Genetic Determinants of Cardiovascular-Kidney-Metabolic Syndrome
Funded at Utah State Higher Education System--University of Utah · NIH-11319639 · Data updated 2026-11-12
A research project looks for genetic clues that connect heart, kidney, and diabetes risks in Native Hawaiians and Pacific Islanders to improve understanding and care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Utah State Higher Education System--University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | September 1, 2026 |
| Project end | April 30, 2031 |
| Funding year | 2026 |
| Award (this year) | $769,998 |
| NIH project number | 1R01MD021648-01A1 |
| Project ID | NIH-11319639 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults of Native Hawaiian and Pacific Islander descent who are part of the UPIS or similar NHPI cohorts and have or are at risk for CKM-related conditions.
✕Less likely to help
People without NHPI background or not involved in CKM-related conditions may not directly benefit from the findings.
What this research studies
This project studies how genetic differences influence the intertwined risks of heart disease, kidney disease, and type 2 diabetes in Native Hawaiians and Pacific Islanders. Researchers are using long-read whole-genome sequencing to build a distinctive NHPI genetic reference and identify population-specific variants that affect CKM risk. The work involves analyzing phenotypic and multi-omics data from over 800 participants in the UPIS to connect genetics with disease pathways. The ultimate goal is to better predict risk and tailor prevention and treatment for NHPI communities, addressing a major health disparity.
Why it matters
Potential benefit: If successful, findings could lead to personalized prevention and treatment strategies for CKM-related conditions in NHPI populations.
How similar studies have gone: Preliminary genetic and multi-omics work has already identified population-specific variants linked to diabetes and kidney disease risk in NHPI populations.
Where this research is happening
-
Utah State Higher Education System--University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Pezzolesi, Marcus Guy — Utah State Higher Education System--University of Utah
- Study coordinator: Pezzolesi, Marcus Guy
Related research
Other NIH-funded projects on the same topics.
-
Integrated biomarker study of metabolic syndrome in pregnant women with HIV on DTG-based ART
Researchers will look for biological signs in pregnant women with HIV on a DTG-based regimen to understand why weight gain and metabolic problems happen and how these affect pregnancy.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based ART
This project looks at why some pregnant women living with HIV on a common DTG-based therapy gain weight or develop metabolic problems, by studying their proteins and metabolites across four sites in the US and Nigeria.
-
Biomarker profiling to understand metabolic syndrome in pregnant women with HIV on DTG-based therapy
This project looks at markers in pregnant women living with HIV who are on a DTG-containing regimen to understand why some develop metabolic problems during pregnancy.
-
Metabolic syndrome and brain support cells: how it may lead to Alzheimer’s disease
A researcher is studying how midlife metabolic problems like diabetes and obesity may disrupt brain cells that support neurons, potentially leading to Alzheimer's disease and related dementia in later life.
-
GLP-1 medicines to improve heart, kidney, and metabolic health for people with HIV and type 2 diabetes
A real-world study will look at how GLP-1 receptor agonists affect heart and kidney health and lifetime costs for people living with HIV and type 2 diabetes.
-
A new metabolic risk score to predict heart disease in Yup’ik Alaska Native adults
A new, questions-free way to measure heart-disease risk in Yup’ik Alaska Native adults by combining everyday health clues with home-life factors.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.